Literature DB >> 14669533

Prognostic value of interleukin-1 beta levels after acute brain injury.

Alptekin Taşçi1, Onder Okay, Ali Riza Gezici, Rüçhan Ergün, Fikret Ergüngör.   

Abstract

Traumatic injury to central nervous system results in the production of inflammatory cytokines via intrinsic mechanisms by neurons, astrocytes and microglia, and extrinsic mechanisms by infiltrating macrophages, lymphocytes and other leukocytes. Interleukin-1 beta is the key mediator of the acute inflammatory host response. While this response is necessary for resolution of the pathologic event, the toxic nature of many of its products can cause significant tissue damage. We analyzed serum interleukin-1 beta levels by enzyme-linked immunosorbent assay in 48 patients with solitary head injury who were transported to our clinic immediately after trauma. We categorized the patients according to their initial Glasgow coma scores in three groups, and compared their serum interleukin-1 beta values both with their Glasgow coma initial and outcome scores. This study helped to provide quantitative data to estimate clinical impressions and prognosis after head injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669533     DOI: 10.1179/016164103771953998

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  17 in total

Review 1.  Traumatic alterations in consciousness: traumatic brain injury.

Authors:  Brian J Blyth; Jeffrey J Bazarian
Journal:  Emerg Med Clin North Am       Date:  2010-08       Impact factor: 2.264

2.  Acute elevation of serum inflammatory markers predicts symptom recovery after concussion.

Authors:  Morgan E Nitta; Jonathan Savitz; Lindsay D Nelson; T Kent Teague; James B Hoelzle; Michael A McCrea; Timothy B Meier
Journal:  Neurology       Date:  2019-07-03       Impact factor: 9.910

3.  Compound 21, a Direct AT2R Agonist, Induces IL-10 and Inhibits Inflammation in Mice Following Traumatic Brain Injury.

Authors:  Saifudeen Ismael; Tauheed Ishrat
Journal:  Neuromolecular Med       Date:  2021-09-20       Impact factor: 4.103

4.  A Prospective Study of Acute Blood-Based Biomarkers for Sport-Related Concussion.

Authors:  Timothy B Meier; Daniel L Huber; Luisa Bohorquez-Montoya; Morgan E Nitta; Jonathan Savitz; T Kent Teague; Jeffrey J Bazarian; Ronald L Hayes; Lindsay D Nelson; Michael A McCrea
Journal:  Ann Neurol       Date:  2020-04-20       Impact factor: 10.422

5.  MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury.

Authors:  Saifudeen Ismael; Sanaz Nasoohi; Tauheed Ishrat
Journal:  J Neurotrauma       Date:  2018-04-02       Impact factor: 5.269

Review 6.  Clinical evidence of inflammation driving secondary brain injury: a systematic review.

Authors:  Holly E Hinson; Susan Rowell; Martin Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2015-01       Impact factor: 3.313

7.  Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury.

Authors:  Hilaire J Thompson; Sarah R Martha; Jin Wang; Kyra J Becker
Journal:  J Head Trauma Rehabil       Date:  2020 Sep/Oct       Impact factor: 3.117

Review 8.  Monitoring biomarkers of cellular injury and death in acute brain injury.

Authors:  Sherry H-Y Chou; Claudia S Robertson
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

9.  The role of markers of inflammation in traumatic brain injury.

Authors:  Thomas Woodcock; Maria Cristina Morganti-Kossmann
Journal:  Front Neurol       Date:  2013-03-04       Impact factor: 4.003

10.  Altered Blood Biomarker Profiles in Athletes with a History of Repetitive Head Impacts.

Authors:  Alex P Di Battista; Shawn G Rhind; Doug Richards; Nathan Churchill; Andrew J Baker; Michael G Hutchison
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.